基于生物信息学和实验验证的系统分析确定了Alox5作为氏素治疗败血症的新治疗标
Chu-Yun Liu1, Yu-Shen Yang1, Meng-Qin Pei1
1Department of Anesthesiology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian Province, China.
Annals of medicine
|October 10, 2024
概括
素治疗败血症的治疗确定了阿拉基多酸-5-氧化酶 (Alox5) 作为一个关键的目标. 奎尔赛丁有效抑制了Alox5和炎症,这表明Alox5在败血症进展中至关重要.
科学领域:
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 败血症是一种危及生命的疾病,其特点是宿主对感染的反应失调.
- 了解导致败血症的分子机制对于开发有效的治疗方法至关重要.
研究的目的:
- 研究奎尔丁在治疗败血症中的分子机制.
- 通过网络药理学和实验验证,通过网络药理学和实验验证来确定血症中素的关键分子标.
主要方法:
- 网络药理学预测整合差异表达基因 (DEGs),权重基因联合表达网络分析 (WGCNA),奎尔丁点和与铁亡相关的基因.
- 核心基因的识别和验证,特别是阿拉基酸5-氧酶 (Alox5) 的识别和验证.
- 使用体外和体外败血症模型进行实验验证.
主要成果:
- 阿拉基多酸5-氧化酶 (Alox5) 被确定为败血症中关键的氨酸相关基因.
- 在败血症中,Alox5表达与炎症,免疫反应和巨细胞透相关.
- 奎尔丁治疗抑制了Alox5上调和败血症诱导的炎症在体外和体内.
结论:
- 阿洛克斯5在败血症多器官功能障碍的发展中发挥着重要作用.
- 艾洛克斯5是治疗败血症治疗中的可靠治疗素标.
相关概念视频
Gene Regulation in Microbial Communities: Quorum Sensing
3
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
3
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K


